Abbvie Discontinues Manufacturing of the Androgel 1% Pump

[Anonymous]

Thoughts?

 

[Anonymous]

Thoughts?

Happy thoughts keep thinking happy thoughts!

 

[Anonymous]

Where does this crap come from?

 

[Anonymous]

Probably a good thing. It became an unnecessary option with the evolution to 1.62% version. Despite the name, 1.62% more convenient than previous iteration for all parties - most importantly, the patient.

 

[Anonymous]

Two pumps vs four pumps? Gee, a medical miracle! How can you even talk about it?

 

[Anonymous]

absorption rate, titration differential, less shelf space required both in pharmacy and in medicine cabinet, packaging costs...but you're right, half the actuations is not too difficult to understand.

 

[Anonymous]

Hate to state the obvious but lets look at this from a big picture perspective. Obviously they are preparing for generic 1% due out any day now. That will not only displace Andro 1% current trx and nrx volume but will quickly knock 1.62 to the curb for most current and new scripts as well.

Beginning of the end for Androgel. Generics rule the US and are more in the drivers seat then ever. Goood luck selling those lame "advantages" of 1.62 to patients, docs, Ocare, Medicare and insurance companies.

 

[Anonymous]

How do you figure a generic any day now? If so why just the pump and not the packet?

 

[Anonymous]

Diff OP here. The pump packet what the hell is the difference. They are leaving packet out only to suck any minimal life left.
tic toc. Its all about cost period.